Marc Stapley, Director, Chief Executive Officer, on June 02, 2026, sold 138,051 shares in Veracyte (VCYT) for $6,919,585. Following the Form 4 filing with the SEC, Stapley has control over a total of 440,494 common shares of the company, with 440,494 shares held directly.
SEC Filing: